pH-sensitive Silk Fibroin Nanoparticles Encapsulating β-Hydroxyisovalerylshikonin for Targeted Pancreatic Cancer Therapy
Authors:
- 1 December 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 22 (10) , 1469-1480
Abstract
Background: Pancreatic cancer is a highly malignant tumor with a poor prognosis, and current treatment methods have limited effectiveness. Therefore, developing new and more effective therapeutic strategies is crucial. This study aims to establish pH-responsive silk fibroin (SF) nanoparticles encapsulating β-hydroxyisovalerylshikonin (SF@β-HIVS) to enhance the therapeutic effects against pancreatic cancer. Methods: SF@β-HIVS nanoparticles were prepared using a self-assembly technique and characterized under different pH conditions using scanning electron microscopy (SEM) and dynamic light scattering (DLS). The effects of SF@β-HIVS on the viability, apoptosis, and migration of PANC-1 cells were assessed through in vitro experiments. Additionally, in vivo experiments using a PANC-1 xenograft mouse model evaluated the antitumor activity and biosafety of SF@β-HIVS. Results: SF@β-HIVS nanoparticles exhibited a uniformly distributed spherical structure under pH 7.4 conditions and rapidly disintegrated in acidic environments, releasing the drug. In vitro experiments demonstrated that SF@β-HIVS significantly inhibited PANC-1 cell proliferation, induced apoptosis, and suppressed cell migration. In vivo, experiments confirmed the significant antitumor activity and good biosafety of SF@β-HIVS. Conclusion: This study successfully developed pH-responsive SF@β-HIVS nanoparticles and validated their potential in treating pancreatic cancer. These findings provided a foundation for the clinical application of SF@β-HIVS in pancreatic cancer treatment.Keywords
This publication has 74 references indexed in Scilit:
- Lysosomal-mediated drug release and activation for cancer therapy and immunotherapyAdvanced Drug Delivery Reviews, 2022
- Molecular and biochemical investigation of the protective effects of rutin against liver and kidney toxicity caused by malathion administration in a rat modelEnvironmental Toxicology, 2022
- The Systematic Evaluation of Physicochemical and Biological Properties In Vitro and In Vivo for Natural Silk Fibroin NanoparticlesAdvanced Fiber Materials, 2022
- Structure‐Based Varieties of Polymeric Nanocarriers and Influences of Their Physicochemical Properties on Drug Delivery ProfilesAdvanced Science, 2022
- Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human healthAdvanced Drug Delivery Reviews, 2021
- Early screening and diagnosis strategies of pancreatic cancer: a comprehensive reviewCancer Communications, 2021
- Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modificationBioactive Materials, 2021
- The FTO/miR‐181b‐3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancerCancer Communications, 2020
- Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and PerspectivesAngewandte Chemie International Edition, 2020
- pH‐Dependent Anticancer Drug Release from Silk NanoparticlesAdvanced Healthcare Materials, 2013